MetLife (MET)
(Delayed Data from NYSE)
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$74.34 USD
+0.49 (0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $74.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Zacks News
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Stock Gains 18.2% in 6 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) improving performance in the United States and Asia business, coupled with cost-reduction initiatives, position the company well for growth.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services, MGIC Investment and CNO Financial
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services, MGIC Investment and CNO Financial are part of the Zacks Industry Outlook article.
5 Stocks to Watch From the Prospering Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, HIG, MTG and CNO.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
EverQuote (EVER) Up 17% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Why Is MetLife (MET) Up 6% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
MetLife (MET) Q3 Earnings Miss Despite Rising Investment Returns
by Zacks Equity Research
MetLife (MET) exits the third quarter with cash and cash equivalents of $14.9 billion.
MetLife (MET) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Insurance Stocks' Q3 Earnings Due on Nov 1: AFL, MET & More
by Zacks Equity Research
High interest rates and renewals favor insurers in Q3 but are partly offset by costs and CAT losses. AFL, MET, AIG, ALL & PRU will release earnings on Nov 1.
Will Lower Premiums Hurt MetLife's (MET) Q3 Earnings?
by Zacks Equity Research
MetLife's (MET) third-quarter results are likely to reflect lower premiums and deteriorating profits in the EMEA segment.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Hippo Holdings Inc. (HIPO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hippo Holdings Inc. (HIPO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET) & Nayya Unite to Enhance Insurance Offerings
by Zacks Equity Research
MetLife (MET) announces a strategic partnership with Nayya to improve employee benefits experience.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Zacks Industry Outlook Highlights MetLife, American International, The Hartford Financial Services, Everest and MGIC Investment
by Zacks Equity Research
MetLife, American International, The Hartford Financial Services, Everest and MGIC Investment are part of the Zacks Industry Outlook article.
5 Multiline Insurers Worth Buying Despite Industry Challenges
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, HIG, EG and MTG.